Drug Development Archives

Press Coverage

The Medicine Maker: The Biosimulation Generation

The article, The Biosimulation Generation, explores the transformative potential of biosimulation in pharmaceutical R&D as…

Danielle PillsburyJuly 1, 2025

Blog

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

June 30, 2025 Drug development is increasingly defined by its complexity. Teams must navigate rising…

CertaraJune 30, 2025

Publication

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Due to the highly controlled settings of clinical trials, enrolled subjects may not be fully…

CertaraJune 19, 2025

On-Demand Webinar

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Discover the Real-World Impact of Model-Based Meta-Analysis. Hear from experts, see case studies to advance…

CertaraJune 18, 2025

On-Demand Webinar

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

CertaraJune 11, 2025

Publication

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

The study, published in the Journal of Clinical Pharmacology, evaluates the cardiac safety of fruquintinib,…

CertaraJune 8, 2025

Press Coverage

FDA plans to phase out animal testing requirements

Discover how the FDA plans to replace animal testing with AI and organ-on-chip technologies for…

CertaraApril 10, 2025

Video

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

CertaraMarch 27, 2025

Video

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

CertaraMarch 26, 2025

Video

Behind the Science: Meet Sr. Director Craig Comisar

CertaraMarch 26, 2025

Drug Development

The Medicine Maker: The Biosimulation Generation

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

FDA plans to phase out animal testing requirements

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

Behind the Science: Meet Sr. Director Craig Comisar

Newsletter sign up

Quick links

Solutions

Contact